Pain Therapeutics, Inc. (NASDAQ:PTIE)’s ties with Pfizer Inc. (NYSE:PFE) regarding the development of pain drug, Remoxy, have been terminated. The companies…
Pfizer Inc. (NYSE:PFE) Chairman and CEO, Ian Read, said that the company could witness its key in-line products continuing its solid performance during…
The stalled effort of Sanofi SA (ADR) (NYSE:SNY) to sell its $8 billion drug portfolio happens to be the latest example of how the company’s Chief Executive…
It seems Pfizer Inc. (NYSE:PFE) has put to rest all speculations or hopes of its effort to buy Britain-based AstraZeneca plc (ADR) (NYSE:AZN). The indication…
The probability of Pfizer Inc. (NYSE:PFE) to revitalize its plans of doing a deal with AstraZeneca Plc.(AZN) has been reduced considerably after the failure…
Albany, New York (10/06/2014) – Cisco Systems, Inc. (NASDAQ:CSCO) will lay off 182 people in Boxborough, being part of the networking company’s efforts…
Albany, New York (09/29/2014) – Pfizer Inc. (NYSE:PFE) informed GlycoMimetics Inc (NASDAQ:GLYC) that initiation of the Rivipansel Phase 3 clinical trial…
Albany, New York (09/26/2014) – After receiving the approval receipt from all required U.S. authorities, Pfizer Inc. (NYSE:PFE), today, sealed the deal…
